Introduction: The Intensive Care Unit (ICU) is a hospitalization unit for critically ill
patients, whomostly use sedatives and analgesics. Seeking tominimize undesirable events,
clinical follow-up of patients, especially pediatric patients, is necessary. Objective: To
propose an instrument for pharmacotherapeutic monitoring of patients undergoing
sedoanalgesia in the pediatric ICU. Method: Retrospective study, with data collected from
medical records of patients aged 0 to 14 years, admitted to the pediatric ICU during the
study period, who used sedoanalgesics. Results and discussion: In 326 prescriptions in
the 90-day period involving 96 children, the age group of07-09 years predominated, with
49.2% underweight and predominantly male. Among the drugs prescribed were
antimicrobials, sedoanalgesics, antipyretics and proton pump inhibitors. The average
length of hospital stay was 18.5 days and approximately 32.7% of the patients had
Withdrawal Syndrome (AS), corroborating the literature, where it is postulated that the
longer thetime of use of these drugs, the greater the risk of SA. In 25% of the patients,
42.5% used antidotesother than those recommended by the Pediatrics and Pediatric &
Neonatal Dosage Handbook. Asa product, a Manual for the Use of Sedoanalgesics was
prepared to guide the multidisciplinary team in the care of patients during therapy.
Conclusion: The data from this research indicated anunderweight public, the occurrence
of medication errors and withdrawal syndrome, among otherfactors that reinforce the
need for the elaboration of an institutionalized protocol for the administration of
sedoanalgesics, aiming to guarantee patient safety, prevent the occurrence of adverse
events related to its use and direct the multidisciplinary team on the care to be adopted.
|
